Lanreotide diTFA, a cutting-edge biomedicine of novel nature, is deployed in the intricate realm of acromegaly, an enigmatic hormonal disorder marked by the unwarranted surge in growth hormone secretion. Through virtue of embodying the essence of a somatostatin analog, this wonder drug efficaciously curbs the exocrine release of growth hormone, thus serving as a catalyst in abating the diverse array of notabilities accompanying acromegaly.
Lanreotide diTFA is a synthetic octapeptide analog of somatostatin, modified for enhanced metabolic stability and receptor selectivity. As a peptide compound, it features a unique amino acid sequence engineered to mimic the inhibitory actions of endogenous somatostatin, but with improved pharmacokinetic properties and resistance to enzymatic degradation. The diTFA (ditrifluoroacetate) salt form enhances its solubility and handling characteristics, making it suitable for a range of biochemical and peptide research applications. Lanreotide and its derivatives have become valuable molecular tools for probing somatostatin receptor pharmacology, signal transduction pathways, and peptide-receptor interactions, supporting advanced research in endocrinology, neurobiology, and peptide drug design.
Receptor binding studies: Lanreotide diTFA is widely utilized for in vitro investigations into somatostatin receptor subtypes, particularly SSTR2 and SSTR5. Its high affinity and selectivity profile enable researchers to dissect receptor-ligand interactions, elucidate binding kinetics, and characterize receptor distribution in various tissue models. By employing radiolabeled or fluorescently tagged analogs, scientists can quantitatively assess receptor density, map receptor localization, and explore the molecular basis of somatostatin-mediated signaling.
Peptide structure-activity relationship (SAR) analysis: The compound serves as a reference molecule for SAR studies focused on somatostatin analogs. Its well-defined sequence and stable conformation allow systematic modification and comparative analysis, facilitating the identification of key residues responsible for receptor affinity, selectivity, and bioactivity. Such SAR investigations inform the rational design of next-generation peptide ligands with tailored pharmacological properties for research applications.
Peptide synthesis and analytical method development: Lanreotide diTFA is frequently used as a standard or positive control in peptide synthesis protocols and analytical method validation. Its robust chemical characteristics make it an ideal benchmark for optimizing solid-phase peptide synthesis (SPPS) strategies, HPLC purification processes, and mass spectrometric detection methods. Researchers rely on it to calibrate instrumentation, assess peptide purity, and troubleshoot synthetic workflows in peptide chemistry laboratories.
Cell signaling and functional assay systems: The compound is instrumental in the development and calibration of cell-based assays that investigate somatostatin receptor-mediated signaling pathways. By applying it to cultured cells expressing specific SSTR subtypes, researchers can measure downstream effects such as inhibition of adenylyl cyclase, modulation of ion channel activity, or regulation of hormone secretion. These functional assays provide insights into the mechanisms of G protein-coupled receptor (GPCR) signaling and the cellular consequences of receptor activation or blockade.
Peptide formulation and stability research: Lanreotide diTFA is also employed in studies of peptide formulation, aggregation, and stability, which are critical for advancing peptide-based technologies. Its physicochemical properties make it a model compound for evaluating the impact of excipients, pH, and storage conditions on peptide integrity. Such investigations support the development of robust formulation strategies and inform best practices for handling, storage, and long-term preservation of synthetic peptides in research and industrial contexts.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More